We are live on
!
Find out more
AGM
Alpine Global Management Portfolio holdings
AUM
$668M
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+14.93%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$301M
AUM Growth
-$127M
(-30%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-44.67%
Top 10 Holdings %
Top 10 Hldgs %
57.1%
Holding
842
New
352
Increased
28
Reduced
90
Closed
287
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$15.1M |
| 2 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$14.1M |
| 3 |
Cornerstone Strategic Value Fund
CLM
|
+$9.51M |
| 4 |
Albertsons Companies
ACI
|
+$3.96M |
| 5 |
Rivian
RIVN
|
+$3.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$56.5M |
| 2 |
Immunovant
IMVT
|
+$35.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$11.3M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$10.7M |
| 5 |
VMW
VMware, Inc
VMW
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.53% |
| 2 | Technology | 13.41% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 7.02% |
| 5 | Industrials | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LICY
176
DELISTED
Li-Cycle Holdings Corp.
LICY
| $119K | 0.04% |
+3,115
| New | +$140K |
|
177
ACM Research
ACMR
$4.98B
| $118K | 0.04% |
+15,277
| New | +$129K |
|
178
B&G Foods
BGS
$297M
| $118K | 0.04% |
+10,606
| New | +$147K |
|
179
Fastly Inc
FSLY
$3.26B
| $118K | 0.04% |
+14,434
| New | +$126K |
|
180
GoodRx Holdings
GDRX
$1.06B
| $118K | 0.04% |
+25,388
| New | +$125K |
|
181
Navitas Semiconductor
NVTS
$2.61B
| $118K | 0.04% |
+33,533
| New | +$144K |
|
182
Sundial Growers
SNDL
$318M
| $118K | 0.04% |
+56,474
| New | +$134K |
|
|
ACCD
183
DELISTED
Accolade Inc
ACCD
| $118K | 0.04% |
+15,101
| New | +$144K |
|
|
DSEY
184
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $118K | 0.04% |
+27,701
| New | +$136K |
|
|
DHC
185
Diversified Healthcare Trust
DHC
$2.28B
| $117K | 0.04% |
+180,726
| New | +$178K |
|
186
DraftKings
DKNG
$12.2B
| $117K | 0.04% |
+10,281
| New | +$143K |
|
187
Fulcrum Therapeutics
FULC
$248M
| $117K | 0.04% |
+16,073
| New | +$105K |
|
|
ILPT
188
Industrial Logistics Properties Trust
ILPT
$603M
| $117K | 0.04% |
+35,890
| New | +$149K |
|
189
Microvision
MVIS
$86.6M
| $117K | 0.04% |
+49,724
| New | +$154K |
|
|
RDFN
190
DELISTED
Redfin
RDFN
| $117K | 0.04% |
+27,477
| New | +$129K |
|
191
Amneal Pharmaceuticals
AMRX
$5.99B
| $116K | 0.04% |
+58,186
| New | +$130K |
|
192
AtaiBeckley Inc
ATAI
$2.66B
| $116K | 0.04% |
+43,664
| New | +$133K |
|
193
Atara Biotherapeutics
ATRA
$70.4M
| $116K | 0.04% |
+1,419
| New | +$148K |
|
194
Codexis
CDXS
$161M
| $116K | 0.04% |
+24,885
| New | +$136K |
|
|
HIMX
195
Himax Technologies
HIMX
$2.09B
| $116K | 0.04% |
+18,612
| New | +$118K |
|
196
Lucid Motors
LCID
$3.08B
| $116K | 0.04% |
+1,703
| New | +$187K |
|
197
LegalZoom.com
LZ
$1.39B
| $116K | 0.04% |
+14,989
| New | +$130K |
|
198
Pacific Biosciences
PACB
$432M
| $116K | 0.04% |
+14,192
| New | +$122K |
|
|
SFIX
199
Stitch Fix
SFIX
$563M
| $116K | 0.04% |
+37,146
| New | +$139K |
|
|
YMAB
200
DELISTED
Y-mAbs Therapeutics
YMAB
| $116K | 0.04% |
+23,866
| New | +$173K |
|
Similar funds
IACCIA
TAP
CWP
WSCM
AO
BCP
SP
LCM
Alpine Global Management's Q4 2022 Portfolio in Review
As of Q4 2022, Alpine Global Management held 842 positions worth $301M, down 30% from $427M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Alpine Global Management withdrew a net $134M in Q4 2022, closing 287 positions and reducing 90 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $56.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Alpine Global Management opened a new position in Tesla worth $9.84M.
- Alpine Global Management's largest Q4 2022 buy was Tesla: 79,871 shares worth $9.84M.
- Alpine Global Management added most to Cornerstone Strategic Value Fund in Q4 2022, an estimated $9.51M increase.
- Alpine Global Management's biggest Q4 2022 reduction was Immunovant, cutting an estimated $35.9M.
- Alpine Global Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $56.5M.
- Alpine Global Management's ten largest holdings make up 57% of its $301M portfolio in Q4 2022.
- Alpine Global Management opened 352 new positions and closed 287 in Q4 2022.
- Alpine Global Management's portfolio value fell 30% quarter-over-quarter to $301M.
Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.